Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
+$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$185M |
| 3 |
WESCO International
WCC
|
+$171M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Delta Air Lines
DAL
|
+$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$154M |
| 3 |
Marsh & McLennan
MMC
|
+$115M |
| 4 |
Johnson & Johnson
JNJ
|
+$99M |
| 5 |
Novo Nordisk
NVO
|
+$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Schlumberger
SLB
$53.4B
| $11.2M | 0.02% |
290,824
-739,592
| -72% | -$28.4M |
|
577
Super Micro Computer
SMCI
$25.5B
| $11M | 0.02% |
360,500
+20,500
| +6% | +$625K |
|
|
ALTR
578
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $11M | 0.02% |
+100,659
| New | +$11M |
|
579
Enovis
ENOV
$1.78B
| $11M | 0.02% |
+250,000
| New | +$11M |
|
580
J.M. Smucker
SJM
$11.8B
| $10.9M | 0.02% |
99,427
-900
| -0.9% | -$99.1K |
|
581
Datadog
DDOG
$49B
| $10.9M | 0.02% |
76,500
-188,500
| -71% | -$26.9M |
|
582
Genuine Parts
GPC
$19.3B
| $10.9M | 0.02% |
+93,315
| New | +$10.9M |
|
583
Apogee Therapeutics
APGE
$2.29B
| $10.9M | 0.02% |
+240,200
| New | +$10.9M |
|
584
Gen Digital
GEN
$18.1B
| $10.7M | 0.02% |
391,617
-119,000
| -23% | -$3.26M |
|
585
Pegasystems
PEGA
$9.75B
| $10.7M | 0.02% |
+230,000
| New | +$10.7M |
|
586
First Industrial Realty Trust
FR
$6.79B
| $10.7M | 0.02% |
212,885
-119,010
| -36% | -$5.97M |
|
587
ResMed
RMD
$40.9B
| $10.6M | 0.02% |
46,539
+35,103
| +307% | +$8.03M |
|
588
TScan Therapeutics
TCRX
$104M
| $10.6M | 0.02% |
3,500,000
-900,000
| -20% | -$2.74M |
|
589
Nordson
NDSN
$12.5B
| $10.6M | 0.02% |
50,800
+18,500
| +57% | +$3.87M |
|
590
Norwegian Cruise Line
NCLH
$11.5B
| $10.6M | 0.02% |
410,800
-3,700
| -0.9% | -$95.2K |
|
591
Merus
MRUS
$5.18B
| $10.5M | 0.02% |
250,000
+65,000
| +35% | +$2.73M |
|
592
UDR
UDR
$12.9B
| $10.4M | 0.02% |
240,500
-77,626
| -24% | -$3.37M |
|
593
Atlas Energy Solutions
AESI
$1.3B
| $10.4M | 0.02% |
469,843
+99,843
| +27% | +$2.21M |
|
594
Brown & Brown
BRO
$30.8B
| $10.4M | 0.02% |
+101,800
| New | +$10.4M |
|
595
Klaviyo
KVYO
$9.64B
| $10.3M | 0.02% |
250,000
-200,000
| -44% | -$8.25M |
|
596
Trevi Therapeutics
TRVI
$1.03B
| $10.3M | 0.02% |
+2,500,000
| New | +$10.3M |
|
|
LINE
597
Lineage, Inc. Common Stock
LINE
$9.54B
| $10.2M | 0.02% |
175,000
+25,000
| +17% | +$1.46M |
|
598
Digi International
DGII
$1.28B
| $10.2M | 0.02% |
337,748
-161,252
| -32% | -$4.87M |
|
599
Sysco
SYY
$38.7B
| $10.2M | 0.02% |
+133,224
| New | +$10.2M |
|
600
enGene Holdings
ENGN
$284M
| $10.2M | 0.02% |
1,529,768
-800,000
| -34% | -$5.32M |
|